NeuroBo Pharmaceuticals Reports First Quarter 2021 Financial Results
Go back to NeuroBo Pharmaceuticals Reports First Quarter 2021 Financial Results| (NASDAQ: GEMP) | Delayed: 0.30 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.30 | 52 Week High | $13.98 | |||
| Open | $58.27 | 52 Week Low | $8.50 | |||
| Day High | $0.30 | P/E | N/A | |||
| Day Low | $0.30 | EPS | $0.00 | |||
| Volume | 6,852 | |||||
| Neuro Bioscience, Inc. New (NASDAQ: NRBO) | Delayed: 2.36 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.36 | 52 Week High | $0.00 | |||
| Open | $2.36 | 52 Week Low | $0.00 | |||
| Day High | $2.36 | P/E | N/A | |||
| Day Low | $2.36 | EPS | $0.00 | |||
| Volume | 8 | |||||
